Transaction · 0001213900-26-103535

Gabay Avraham

Gabay Avraham, CFO, reported a transaction classified as grant at ORAMED PHARMACEUTICALS INC. involving 209291.000000 shares. Reported holdings after the transaction were 881076.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
ORMPORAMED PHARMACEUTICALS INC.
Filing timeSep 25
Trade dateSep 24, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$5.07
Pre-filing
1mo ago +0.0%1w ago +0.0%1d ago +0.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

ORMP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ORMP since 2026-09-25Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001213900-26-103535
Common Stock
Transaction date
Sep 24, 2026
Filed Sep 25, 2026, 08:30 PM · 1d delay
Shares
209k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
881k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-20score
Filing-only score

-20

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On September 24, 2026, the issuer granted to the reporting person a restricted stock award of an aggregate of 209,291 shares pursuant to the issuer's Amended and Restated 2019 Stock Incentive Plan (th…

Original filing · 0001213900-26-103535
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ORMP